 |
Page History
| Excerpt |
|---|
RAPID Stage is a real time surveillance system which will allow FDA to collect adverse events (AE) on emergency use of any FDA approved medical product during emergent health situations through mobile devices, or EHR information transmission systems. FDA will use cloud based, integrated tools and decision strategies to analyze, validate received and visualized AE reporting on regulatory dashboard and transmit public health information directly to healthcare professionals and organizations within 24 hours. |
BIO:
Dr. Henry Francis is the Director of the Data Mining and Informatics Evaluation and Research Group in the Office of Translational Sciences, Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA). In that capacity he directs a transdisciplinary group of senior sciences to test, create, and operate data analysis programs facilitating the efficient use of scientific methods to evaluate complex data information in order to make regulatory decisions for drug approval and drug safety. Dr. Francis’ specific interest is in the development of data mining techniques to enhance pharmacovigliance capabilities in national medication use and health care databases.
...
